Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-01 14:38:06 UTC |
---|
Update Date | 2021-09-26 22:48:59 UTC |
---|
HMDB ID | HMDB0242533 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Ibogamine |
---|
Description | Ibogamine belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. Ibogamine persistently reduced the self-administration of cocaine and morphine in rats. Ibogamine is a very strong basic compound (based on its pKa). Basic research related to how addiction affects the brain has used this chemical. While the related alkaloids Ibogaine(20-40 mg/kg), harmaline (10-40 mg/kg) and desethylcoronaridine (10-40 mg/kg) were "obviously tremorgenic". Ibogamine is an alkaloid found in Tabernanthe iboga. . The same study found that Ibogamine (40mg/kg) and Coronaridine (40mg/kg) did not produce "any tremor effects in rats that differ significantly from saline control". This compound has been identified in human blood as reported by (PMID: 31557052 ). Ibogamine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Ibogamine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCC1CC2CC3C1N(C2)CCC1=C3NC2=CC=CC=C12 InChI=1S/C19H24N2/c1-2-13-9-12-10-16-18-15(7-8-21(11-12)19(13)16)14-5-3-4-6-17(14)20-18/h3-6,12-13,16,19-20H,2,7-11H2,1H3 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C19H24N2 |
---|
Average Molecular Weight | 280.415 |
---|
Monoisotopic Molecular Weight | 280.193948781 |
---|
IUPAC Name | 17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene |
---|
Traditional Name | 17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCC1CC2CC3C1N(C2)CCC1=C3NC2=CC=CC=C12 |
---|
InChI Identifier | InChI=1S/C19H24N2/c1-2-13-9-12-10-16-18-15(7-8-21(11-12)19(13)16)14-5-3-4-6-17(14)20-18/h3-6,12-13,16,19-20H,2,7-11H2,1H3 |
---|
InChI Key | LRLCVRYKAFDXKU-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Ibogan-type alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Ibogan-type alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Ibogan skeleton
- Catharanthine skeleton
- Pyrroloazepine
- 3-alkylindole
- Indole
- Indole or derivatives
- Azepine
- Aralkylamine
- Piperidine
- Benzenoid
- Pyrrole
- Heteroaromatic compound
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic nitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Ibogamine,1TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC=CC=C1N4[Si](C)(C)C | 2662.2 | Semi standard non polar | 33892256 | Ibogamine,1TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC=CC=C1N4[Si](C)(C)C | 2548.1 | Standard non polar | 33892256 | Ibogamine,1TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC=CC=C1N4[Si](C)(C)C | 3192.7 | Standard polar | 33892256 | Ibogamine,1TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC=CC=C1N4[Si](C)(C)C(C)(C)C | 2846.2 | Semi standard non polar | 33892256 | Ibogamine,1TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC=CC=C1N4[Si](C)(C)C(C)(C)C | 2827.6 | Standard non polar | 33892256 | Ibogamine,1TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC=CC=C1N4[Si](C)(C)C(C)(C)C | 3303.8 | Standard polar | 33892256 |
|
---|